Close Menu

 NEW YORK (360Dx)- With a new 8,000 square-foot laboratory in Rolle, Switzerland, NeoGenomics plans to precisely replicate the full spectrum of specialty oncology lab services that the company offers through its six labs in the United States.

The goal is to be able to offer pharmaceutical clients who work with NeoGeonomic for cancer drug and diagnostics development a process that is consistent across the US and Europe, executives said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.